141
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Bilateral Diffuse Uveal Melanocytic Proliferation Initially Presented as Glaucoma

, MD, , MD, , MD, , MD, , MD & , MDORCID Icon
Pages 601-608 | Received 09 Dec 2021, Accepted 15 Jan 2022, Published online: 24 Feb 2022

References

  • Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010;85:838–854. doi:10.4065/mcp.2010.0099.
  • Verdaguer J, Oporto J. Bilateral diffuse uveal melanocytic proliferation associated with renal cell carcinoma. Retin Cases Brief Rep. 2013;7:137–139. doi:10.1097/ICB.0b013e31826f08c3.
  • O’Neal KD, Butnor KJ, Perkinson KR, Proia AD. Bilateral diffuse uveal melanocytic proliferation associated with pancreatic carcinoma: a case report and literature review of this paraneoplastic syndrome. Surv Ophthalmol. 2003;48:613–625. doi:10.1016/j.survophthal.2003.08.005.
  • Joseph A, Rahimy E, Sarraf D. Bilateral diffuse uveal melanocytic proliferation with multiple iris cysts. JAMA Ophthalmol. 2014;132:756–760. doi:10.1001/jamaophthalmol.2014.311.
  • Machemer R. On the pathogenesis of the flat malignant melanoma. Klin Monbl Augenheilkd. 1966;148:641–652.
  • Miles SL, Niles RM, Pittock S, et al. A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes. Retina. 2012;32:1959–1966. doi:10.1097/IAE.0b013e3182618bab.
  • Jaben EA, Pulido JS, Pittock S, Markovic S, Winters JL. The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases. J Clin Apher. 2011;26:356–361. doi:10.1002/jca.20310.
  • Mets RB, Golchet P, Adamus G, et al. Bilateral diffuse uveal melanocytic proliferation with a positive ophthalmoscopic and visual response to plasmapheresis. Arch Ophthalmol. 2011;129:1235–1238. doi:10.1001/archophthalmol.2011.277.
  • Gass JD, Gieser RG, Wilkinson CP, Beahm DE, Pautler SE. Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma. Arch Ophthalmol. 1990;108:527–533. doi:10.1001/archopht.1990.01070060075053.
  • Pulido JS, Flotte TJ, Raja H, et al. Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation. Eye (Lond). 2013;27:1058–1062. doi:10.1038/eye.2013.131.
  • Klemp K, Kiilgaard JF, Heegaard S, et al. Bilateral diffuse uveal melanocytic proliferation: case report and literature review. Acta Ophthalmol. 2017;95:439–445. doi:10.1111/aos.13481.
  • Sharma M, Yangzes S, Singh SR, Dogra M. Bilateral diffuse uveal melanocytic proliferation in a patient with recurrent frontal lobe meningioma. Ocul Immunol Inflamm. 2021;23:1–4.
  • Jabbarpoor Bonyadi MH, Ownagh V, Rahimy E, Soheilian M. Giraffe or leopard spot chorioretinopathy as an outstanding finding: case report and literature review. Int Ophthalmol. 2019;39:1405–1412. doi:10.1007/s10792-018-0948-5.
  • Sen J, Clewes AR, Quah SA, et al. Presymptomatic diagnosis of bronchogenic carcinoma associated with bilateral diffuse uveal melanocytic proliferation. Clin Exp Ophthalmol. 2006;34:156–158. doi:10.1111/j.1442-9071.2006.01145.x.
  • Alrashidi S, Aziz AA, Krema H. Bilateral diffuse uveal melanocytic proliferation: a management dilemma. BMJ Case Rep. 2014;2014:bcr2014204387–bcr2014204387. doi:10.1136/bcr-2014-204387.
  • Schelvergem KV, Wirix M, Nijs I, Leys A. Bilateral diffuse uveal melanocytic proliferation with good clinical response to plasmapheresis and treatment of the primary tumor. Retin Cases Brief Rep. 2015;9:106–108. doi:10.1097/icb.0000000000000104.
  • Menezes C, Carvalho R, Neves-Martins J, Teixeira C. Bilateral diffuse uveal melanocytic proliferation presenting as a giant unilateral choroidal nevus: a case report. Ocul Oncol Pathol. 2015;2:54–58. doi:10.1159/000438944.
  • Jansen JC, Van Calster J, Pulido JS, et al. Early diagnosis and successful treatment of paraneoplastic melanocytic proliferation. Br J Ophthalmol. 2015;99:943–948. doi:10.1136/bjophthalmol-2014-305893.
  • Navajas EV, Simpson ER, Krema H, et al. Cancer-associated nummular loss of RPE: expanding the clinical spectrum of bilateral diffuse uveal melanocytic proliferation. Ophthalmic Surg Lasers Imaging. 2011;42:e103–106. doi:10.3928/15428877-20111020-02.
  • Mittal R, Cherepanoff S, Thornton S, et al. Bilateral diffuse uveal melanocytic proliferation: molecular genetic analysis of a case and review of the literature. Ocul Oncol Pathol. 2015;2:94–99. doi:10.1159/000440766.
  • Rahimy E, Coffee RE, McCannel TA. Bilateral diffuse uveal melanocytic proliferation as a precursor to multiple systemic malignancies. Semin Ophthalmol. 2015;30:206–209. doi:10.3109/08820538.2013.835835.
  • Niffenegger JH, Soltero A, Niffenegger JS, Yang S, Adamus G. Prevalence of hepatocyte growth factor and autoantibodies to α-HGF as a new etiology for bilateral diffuse uveal melanocytic proliferation masquerading as neovascular age-related macular degeneration. J Clin Exp Ophthalmol. 2018;9:740. doi:10.4172/2155-9570.1000740.
  • van Noort BC, Keunen JEE, Schlingemann RO, Marinkovic M. Long survival and preservation of good visual acuity in a patient with bilateral diffuse uveal melanocytic proliferation. Ocul Oncol Pathol. 2019;5:75–78. doi:10.1159/000488454.
  • Da Silva MV, Rose K, Krema H. Pigment-induced glaucoma secondary to bilateral diffuse uveal melanocytic proliferation. Eur J Ophthalmol. 2020;25:1120672120953076.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.